Research On The Unborn: What Is Our Ethical Stance

It is never an easy task to do science with human subjects, and I do not suggest that it should be. It is even harder to do science with unborn human subjects and, again, this is not legitimate cause for complaint. But it is occasion for complaint—and for remedial action—when science is hampered by public policy that is ambiguous quixotic, or even confused. And that is the case with research on unborn humans. In 1978 the theft Secretary of Health, Education, and Human Welfare re

Written byClifford Grobstein
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

It is never an easy task to do science with human subjects, and I do not suggest that it should be. It is even harder to do science with unborn human subjects and, again, this is not legitimate cause for complaint. But it is occasion for complaint—and for remedial action—when science is hampered by public policy that is ambiguous quixotic, or even confused. And that is the case with research on unborn humans.

In 1978 the theft Secretary of Health, Education, and Human Welfare received from the HEW Ethics Advisory Board a report stating that, in the board’s judgment, research on early human developmental stages could be conducted ethically under circumstances yet to be specified. The board indicated its willingness to consider particular cases and to make appropriate recommendations However, shortly thereafter reappointments to the board were not made by the secretary, and the board ceased to exist. Because an ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies